Steroid cataracts in children

Article

Paediatric subjects who require frequent steroid therapy are at an increased risk of developing amblyopia due to cataracts, according to a study published online ahead of print by Pediatrics International, the official English language publication of the Japan Pediatric Society.

Paediatric subjects who require frequent steroid therapy are at an increased risk of developing amblyopia due to cataracts, according to a study published online ahead of print by Pediatrics International, the official English language publication of the Japan Pediatric Society.

Yasuhito Nerome, MD of the Department of Pediatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan and colleagues evaluated risk factors for the formation of cataracts in paediatric subjects.

The researchers found a positive association between cataract formation and intravenous methylprednisone pulse (IVMP) therapy in subjects aged ≤12 years. No relationship to cataract formation was found to exist with either the doses (cumulative or daily) of steroids used or with patient gender.

Thus the researchers recommended that, since corticosteroid use is associated with cataract formation in paediatric subjects, these patients be examined by ophthalmologists frequently, to reduce the risk of amblyopia.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.